208 RTX-224, an engineered allogeneic red cell therapeutic expressing 4–1BBL and IL-12, activates immune cells in blood and spleen to promote tumor growth inhibition in mice
oleh: Sivan Elloul, Anne-Sophie Dugast, Shannon McArdel, Enping Hong, Maegan Hoover, Laurence Turka, Zafira Castano, Arjun Reddy Bollampalli, Shannon Leonard, Ryan Pepi, Alex Nanna
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.